Mats Anders Nilsson
Chief Executive Officer at KARESSA PHARMA HOLDING AB (PUBL)
Mats Anders Nilsson active positions
| Companies | Position | Start | End |
|---|---|---|---|
| KARESSA PHARMA HOLDING AB (PUBL) | Chief Executive Officer | 2017-12-31 | - |
| Investor Relations Contact | 2017-12-31 | - | |
| Public Communications Contact | 2017-12-31 | - |
Career history of Mats Anders Nilsson
Statistics
International
| Sweden | 2 |
Operational
| Chief Executive Officer | 1 |
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Sectoral
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Karessa Pharma Holding AB
 Karessa Pharma Holding AB Pharmaceuticals: MajorHealth Technology Karessa Pharma Holding AB engages in the development and commercialization of products in the therapeutic area of erectile dysfunction. Its patented drug is an alignate-based polymer film that is applied to the oral mucosa, which then rapidly delivered out into the bloodstream. The company was founded by Fredrik Hubinette on September 11, 2013 and is headquartered in Taby, Sweden. | Health Technology |
- Stock Market
- Insiders
- Mats Anders Nilsson
- Experience
